Abstract
Methods In this randomized trial (the Assessing Screening Plus brief Intervention’s Resulting Efficacy to stop drug use (ASPIRE) study) we tested the efficacy of a brief negotiated interview (BNI), and an adaptation of motivational interviewing (AMI), compared to no BI. Primary care patient participants had Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) drug specific scores of ≥4. Primary outcome at 6 months was number of days use of the drug of most concern (DOMC) in the past 30 days.
Highlights
The efficacy of universal screening and brief intervention (SBI) for drug use among primary care (PC) patients is unknown
Mean adjusted days use of the drug of most concern (DOMC) at 6 months was 11.5 vs. 11.2 (BNI) (incidence rate ratio (IRR) 0.97, 95% CI 0.77-1.22) and 12.1 (AMI) (IRR 1.05, 95% CI 0.84-1.32)
If other trials yield consistent results, widespread implementation of drug screening and BI should be reconsidered, and research should focus on alternative ways to address drug use and consequences in primary care settings
Summary
Screening and brief intervention for drug use in primary care: the Assessing Screening Plus brief Intervention’s Resulting Efficacy to stop drug use (ASPIRE) randomized trial. Richard Saitz1,2*, Tibor P Palfai, Debbie M Cheng, Daniel P Alford, Judith A Bernstein, Christine A Lloyd-Travaglini, Seville M Meli, Christine E Chaisson, Jeffrey H Samet. From International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) Meeting 2013 Rome, Italy. From International Network on Brief Interventions for Alcohol and Other Drugs (INEBRIA) Meeting 2013 Rome, Italy. 18-20 September 2013
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
